Cost of prostate cancer surgery varies widely in the US

Cost of prostate cancer surgery varies widely in the U.S.

(HealthDay)—The open market cost of a radical prostatectomy (RP) varies widely in U.S. hospitals, according to research published in the March issue of Urology.

Scott C. Pate, M.D., of the University of Iowa in Iowa City, and colleagues conducted a of a cohort of 100 U.S. hospitals to solicit price information for RP. The authors used a caller profile of an uninsured 55-year-old man recently diagnosed with Gleason 3 + 4 prostatic adenocarcinoma.

The researchers found that 70 hospitals provided facility prices for RP averaging $34,720 ± 20,335 (range, $10,100 to $135,000). The facility cost for RP was significantly higher at academic centers compared with private hospitals. No significant differences in cost were observed according to region, population, or ranking. Only 10 percent of hospitals provided price information for surgeon and anesthesia fees (average, $8,280 ± 4,282; range, $4,028 to $18,720). Discounts on fees (average, 34 ± 16 percent; range 10 to 80 percent) for prompt payment were offered by 33 hospitals.

"Currently, it appears to be unacceptably difficult for men with prostate cancer without insurance to obtain prices for an RP procedure," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Prostate cancer surgery better at teaching hospitals

Nov 07, 2011

Prostate cancer patients who undergo radical prostatectomy get better results at teaching hospitals than at non-academic medical institutions, according to the findings of an international study led by researchers at Henry ...

Thermal sensation spared in nerve-sparing prostatectomy

Sep 13, 2012

(HealthDay)—Penile thermal sensory thresholds increase after non-nerve-sparing radical prostatectomy (RP) but not after the nerve-sparing procedure, according to a study published in the September issue ...

Recommended for you

Stopping liver cancer in its tracks

31 minutes ago

A University of Tokyo research group has discovered that AIM (Apoptosis Inhibitor of Macrophage), a protein that plays a preventive role in obesity progression, can also prevent tumor development in mice ...

HHS releases 13th Report on Carcinogens

56 minutes ago

Four substances have been added in the U.S. Department of Health and Human Services 13th Report on Carcinogens, a science-based document that identifies chemical, biological, and physical agents that are ...

Dog's epigenome gives clues to human cancer

2 hours ago

The bond between humans and dogs is strong and ancient. From being the protector of the first herds in a faithful pet, dogs and people share many aspects of life. The relationship between the two species ...

User comments